Trump Secures Price Cuts for GLP-1 Drugs Amid Market Dynamics
President Donald Trump has announced agreements with drug manufacturers Eli Lilly and Novo Nordisk aimed at reducing prices for GLP-1 weight-loss medications under Medicare and Medicaid. This move is part…